"Today’s blog is actually a vlog—and a bit of a departure from previous ones. The attached video is an excerpt of a speech about coping with cancer. It is focused on the insights I had, along with the life lessons that emerged. My care team at the Lurie Cancer Center has kept me alive for the last year and a half. Staying true to these life lessons has allowed me to not just be alive, but back in my life. If you have 14 minutes to spare, take a look—it might just help you, too."
About Chuck Maniscalco
Diagnosed with Stage IV lung cancer in October 2016, Chuck benefitted from the advanced, individualized and research-based treatment options offered at the Lung OncoSET, part of the Lurie Cancer Center.
Chuck retired after a long and accomplished career in business, including roles as President of Gatorade, CEO of Quaker, Tropicana and Gatorade, and CEO of Seventh Generation. A man of many passions, he was an avid runner and guitar player, and took daily joy in completing the New York Times crossword puzzle. Chuck passed away March 19, 2019 at his home in Winnetka.
About Lung OncoSET
The Lung OncoSET is an extension of the Lurie Cancer Center's breakthrough OncoSET Program. OncoSET (Sequence, Evaluate, Treat) is based on the premise that each individual and every person's cancer is unique. It harnesses the power of precision medicine to identify tailored therapies for patients based on the abnormal genes specific to their tumor.
In 2014, the Lurie Cancer Center became the first academic cancer center in Chicago and one of only a handful in the nation to provide this kind of personalized medicine to patients with tumors — especially those tumors that are resistant to traditional cancer therapies. Learn more about Lung OncoSET and support more effective treatments for patients with lung cancer.